Bio Rad Laboratories Incorporated operates in the Analytical instruments sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Bio Rad Laboratories Incorporated with three other
companies in this sector in the United States:
sales of $2.26 billion
of which 61%
was Human Health),
of which 100%
was Genotyping Products), and
of which 44%
was Waters Division).
Bio Rad Laboratories Incorporated reported sales of $2.02 billion
December of 2015.
decrease of 7.2%
versus 2014, when the company's sales were $2.18 billion.
The sales level in 2015 was fairly close to the level five years ago: in 2010, Bio Rad Laboratories Incorporated had sales
of $1.93 billion.
Contributing to the drop in overall sales was the 8.5% decline
in Clinical Diagnostics, from $1.43 billion to $1.31 billion.
There were also decreases in sales in
Life Science (down 4.6% to $695.00 million)
Other Operations (down 2.8% to $14.00 million)